Effectiveness and safety of recombinant zoster vaccine: a review of real-world evidence
R Parikh, D Singer, E Chmielewski-Yee… - Human Vaccines & …, 2023 - Taylor & Francis
The recombinant zoster vaccine (RZV) was licensed in the US for prevention of herpes
zoster (HZ) in 2017. We conducted a literature search (January 1, 2017–August 1, 2023) …
zoster (HZ) in 2017. We conducted a literature search (January 1, 2017–August 1, 2023) …
The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50–59 years
Introduction Recombinant zoster vaccine (RZV) is recommended in the US for prevention of
herpes zoster (HZ) in adults aged≥ 50 years. Vaccination rates remain suboptimal for adults …
herpes zoster (HZ) in adults aged≥ 50 years. Vaccination rates remain suboptimal for adults …
Public health impact of herpes zoster vaccination on older adults in Singapore: a modeling study
H Oh, C Tan, C Williams, N Giannelos… - Human Vaccines & …, 2024 - Taylor & Francis
In Singapore, population aging and rising life expectancy are increasing herpes zoster (HZ)
burden, which may be reduced by vaccination. The present study modeled the public health …
burden, which may be reduced by vaccination. The present study modeled the public health …
Attitudes, barriers, and facilitators to adherent completion of the recombinant zoster vaccine regimen in Canada: Qualitative interviews with healthcare providers and …
S George, J Regan, A Awan, M O'Connor… - Human Vaccines & …, 2024 - Taylor & Francis
This qualitative, cross-sectional study aimed to understand the barriers and facilitators
related to the adherence and completion of the recombinant zoster vaccine (RZV) two-dose …
related to the adherence and completion of the recombinant zoster vaccine (RZV) two-dose …
Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia
R Han, P San Martin, N Ahmed… - Infectious Diseases and …, 2024 - Springer
Introduction Herpes zoster (HZ) can cause substantial patient morbidity and lead to large
healthcare costs. However, the disease burden of HZ in Southeast Asia may be …
healthcare costs. However, the disease burden of HZ in Southeast Asia may be …
2022 national survey of immunizing community chain pharmacists: The case for codifying the PREP Act emergency authorities into practice
A Kulczycki, M Hogue, M Rothholz, J Grubbs… - Journal of the American …, 2024 - Elsevier
Background Pharmacy-based immunization services have expanded since the mid-1990s
but still face multiple challenges. Amendments to the Public Readiness and Emergency …
but still face multiple challenges. Amendments to the Public Readiness and Emergency …